期刊文献+

硝普钠、多巴胺和多巴酚丁胺治疗扩张型心肌病顽固性心力衰竭疗效观察 被引量:4

Sodium nitroprusside,dopamine with dobutamine in treatment of refractory heart failure of dilated cardiomyopathy
下载PDF
导出
摘要 目的:探讨硝普钠、多巴胺和多巴酚丁胺治疗扩张型心肌病顽固性心力衰竭的临床疗效。方法:32例患者给予休息、吸氧、利尿剂、地高辛、血管紧张素转换酶抑制剂(ACEI)类药物常规处理,存在心律失常,给予相应的抗心律失常治疗,同时给予5%葡萄糖注射液250ml+硝普钠10mg+多巴胺40mg+多巴酚丁胺40mg,以10滴/min静脉滴注,3~5d后症状缓解停用硝普钠,继续使用多巴胺和多巴酚丁胺,疗程15d。结果:32例患者治疗后心功能有显著改善(均P<0.05)。结论:硝普钠、多巴胺和多巴酚丁胺治疗扩张型心肌病顽固性心力衰竭疗效明显,安全可靠。 Objective:To explore the clinical effect of sodium nitroprusside,dopamine with dobutamine in treatment of refractory heart failure of dilated cardiomyopathy. Methods:32 cases received regular treatment such as rest, oxygen, diuretic, digoxin, ACEI etc. When arrhythmia existed the drugs for anti-arrhythmia was given. Meanwhile sodium nitroprusside, dopamine with dobutamine were given too. After 3-5 days of symptom relieved, sodium nitroprusside was stoped, dopamine and dobutamine continued, the whole treatment course is 15 days. Results: The heart function in 32 cases improved obviously after treatment(P〈0.05), Conclusion: The curative effect of sodium nitroprusside, dopamine with dobutamine in treatment of refractory heart failure of dilated cardiomyopathy is obvious, safety and credibility.
出处 《中国医药导报》 CAS 2008年第26期178-179,共2页 China Medical Herald
关键词 硝普钠 多巴胺 多巴酚丁胺 扩张型心肌病 顽固性心力衰竭 Sodium nitroprusside Dopamine Dobutamine Refractory heart failure Dilated cardiomyopathy
  • 相关文献

参考文献2

二级参考文献11

  • 1Hunt SA,Baker DW,Chin MH,et al.ACC/ AHA Guidelines for the evaluation and management of chronic heart failure in the adult:executive summarya report of the American college of cardiology/ American heart association taskforce on practice guidelines (committee to revise the 1995 guidelines for the evaluation and management of heart failure)[J].Circulation,2001,104:2996.
  • 2The Digitalis Investigation Group.The effect of digoxin on mortality and morbidity in patients with heart failure[J].N Engl J Med,1997,336:525.
  • 3Rathore SS,Curtis JP,Wang Y,et al.Association of serum digoxin concentration and outcomes in patients with heart failure[J].JAMA,2003,289:871-878.
  • 4Adams KF Jr,Gheorghiade M,Uretsky BF,et al.Clinical benefits of low serum digoxin concentration in heart failure[J].J Am Coll Cardiol,2002,39:946-953.
  • 5Cohn JN,Goldstein SO,Greenberg BH,et al.for the Vesnarinone Trial Investigators.A dose-dependent increase inmortality with vesnarinone among patients with serve heart failure[J].N Engl J Med,1998,339:1810-1816.
  • 6van Veldhuisen DJ,Man in,Veld A J,et al.Double-blind placebo-controlled study df ibopamine and digoxin in patients with mild to moderate heart failure:results of the Dutch Ibopamine Multicenter Trial (DIMT)[J].J Am Coll Cardiol,1993,22:1564 -1573.
  • 7Follath F,Cleland JGF,Just H.Efficacy and safety of intravenous levosimendan,a novel calcium sensitiser,in serve low output faiure (the LIDO study)[J].Lancet,2002,360(9328):196 -202.
  • 8Zairis MN,Apostolatos,Anastasiadis P,et al.The effect of a calcium sensitiser or an inotrope or none in chornic low output decompensated heart faiure:results from the calcium sensitiser or an inotrope or none in chornic low output heart faiure study (CASINO)[J].J Am Coll Cardiol,2004,43 (5):206A-207A.
  • 9Cleland JG,Ghosh J,Freemantle N,et al.Clinical trials update and cumulative meta analyses from the American College of Cardiology:WATCH,SCD-HeFT,DNAM Ⅱ,CASINO,INSP IRE,STRATUS-US,and cardiac resyn chronisation therapy in heart failure[J].Eur J Heart Fail,2004,6 (4):501 -508.
  • 10Cleland JG,Nikitin N,McGowan J.Levosimendan:first in a new class of inodilator for acute and chronic severe heart failure[J].Expert Rev Cardiovasc Ther,2004,2 (1):9219.

共引文献51

同被引文献25

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部